Basel, December 05, 2014 – Today, Novartis senior executives gather in Basel, Switzerland for the first-ever Novartis Africa Day, to review the company’s innovative work in Africa, including growing commercial activity, novel approaches to expand access to high-quality, affordable medicines, local talent development and the company’s Malaria Initiative.

  • Africa’s healthcare challenges are compounded as it begins to face a dual disease burden as non-communicable diseases rise
  • In addition to existing corporate responsibility efforts such as its Malaria …

December 03, 2014 – Sandoz in Brazil has partnered with the Londrina Ministry of Labor, the Londrina State University and other local entities to create INcluir, a unique program that offers professional skills training to people with disabilities. The aim of the program is to build-up the regional talent pool of qualified, disabled workers and to support their employment.

December 03, 2014 – Sandoz in Brazil has partnered with the Londrina Ministry of Labor, the Londrina State University and other local entities to create INcluir, a unique program that offers professional skills training to people with disabilities. The aim of the program is to build-up the regional talent pool of qualified, disabled workers and to support their employment.

December 03, 2014 – Established in 1992, International Day of People with Disabilities is a United Nations sanctioned day that aims to promote an understanding of people with disabilities and encourage support for their dignity, rights and well-being.

People with disabilities often face barriers, including physical, social, economic, educational, attitudinal and health care barriers. There are many types of disabilities and impairments, both visible and invisible.

More than 1 billion people live with a disability, says the world report on disability, published …

December 03, 2014 – Established in 1992, International Day of People with Disabilities is a United Nations sanctioned day that aims to promote an understanding of people with disabilities and encourage support for their dignity, rights and well-being.

People with disabilities often face barriers, including physical, social, economic, educational, attitudinal and health care barriers. There are many types of disabilities and impairments, both visible and invisible.

More than 1 billion people live with a disability, says the world report on disability, published …

December 01, 2014 – According to the World Health Organization (WHO), Human Immunodeficiency Virus (HIV/AIDS) has caused the deaths of millions of people and is one of the most destructive pandemics in history. World AIDS Day, celebrated annually on December 1st, was established by the WHO in 1988 to raise awareness of the virus, which is preventable and treatable.

HIV attacks the body’s immune system, the body’s defense against diseases. HIV can be passed on through infected bodily fluids, most commonly …

December 01, 2014 – According to the World Health Organization (WHO), Human Immunodeficiency Virus (HIV/AIDS) has caused the deaths of millions of people and is one of the most destructive pandemics in history. World AIDS Day, celebrated annually on December 1st, was established by the WHO in 1988 to raise awareness of the virus, which is preventable and treatable.

HIV attacks the body’s immune system, the body’s defense against diseases. HIV can be passed on through infected bodily fluids, most commonly …

Tokyo, Japan, December 1, 2014 ― Sandoz, the generic pharmaceutical division of Novartis, today announced the launch in Japan of biosimilar Filgrastim BS Injection 75µg / 150µg / 300µg Syringe. Filgrastim is used with certain cancer patients to accelerate recovery of infection-fighting white blood cells after chemotherapy (prevention of neutropenia) and is also used to stimulate mobilization of hematopoietic stem cells for collection and transplantation.

“As the pioneer and global leader in biosimilars we are very pleased to announce the launch of our second …

Tokyo, Japan, December 1, 2014 ― Sandoz, the generic pharmaceutical division of Novartis, today announced the launch in Japan of biosimilar Filgrastim BS Injection 75µg / 150µg / 300µg Syringe. Filgrastim is used with certain cancer patients to accelerate recovery of infection-fighting white blood cells after chemotherapy (prevention of neutropenia) and is also used to stimulate mobilization of hematopoietic stem cells for collection and transplantation.

“As the pioneer and global leader in biosimilars we are very pleased to announce the launch of our second …

  • Regulatory authorities in Ireland and Czech Republic grant marketing authorizations for AirFluSal® Forspiro®
  • Approval for 50-250 and 50-500µg dosage forms
  • AirFluSal Forspiro already launched in four European countries and South Korea

Holzkirchen, November 19, 2014 – Sandoz announces today that the pharmaceutical regulatory authorities in Ireland and the Czech Republic have granted marketing authorizations for AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and/or chronic obstructive pulmonary disease (COPD).